Primary |
Depression |
27.5% |
Insomnia |
23.9% |
Sleep Disorder |
9.4% |
Anxiety |
5.7% |
Bipolar Disorder |
5.1% |
Product Used For Unknown Indication |
3.7% |
Major Depression |
3.2% |
Drug Use For Unknown Indication |
2.8% |
Hypertension |
2.5% |
Overdose |
2.5% |
Somnolence |
2.5% |
Mental Disorder |
1.5% |
Sleep Disorder Therapy |
1.5% |
Pain |
1.4% |
Psychotic Disorder |
1.4% |
Suicide Attempt |
1.4% |
Hypothyroidism |
1.1% |
Back Pain |
1.0% |
Constipation |
1.0% |
Migraine |
1.0% |
|
Priapism |
17.8% |
Completed Suicide |
16.8% |
Serotonin Syndrome |
6.6% |
Drug Ineffective |
5.6% |
Drug Toxicity |
5.3% |
Insomnia |
4.6% |
Overdose |
4.6% |
Suicidal Ideation |
4.6% |
Somnolence |
4.3% |
Vomiting |
4.3% |
Product Quality Issue |
3.3% |
Syncope |
3.0% |
Tremor |
3.0% |
Headache |
2.6% |
Drug Interaction |
2.3% |
Myalgia |
2.3% |
Rash |
2.3% |
Suicide Attempt |
2.3% |
Vision Blurred |
2.3% |
Jaundice |
2.0% |
|
Secondary |
Product Used For Unknown Indication |
28.3% |
Drug Use For Unknown Indication |
28.2% |
Depression |
13.4% |
Insomnia |
6.5% |
Anxiety |
5.2% |
Sleep Disorder |
2.7% |
Pain |
2.5% |
Bipolar Disorder |
2.2% |
Diabetes Mellitus |
1.6% |
Hypertension |
1.1% |
Schizophrenia |
1.0% |
Back Pain |
1.0% |
Ill-defined Disorder |
1.0% |
Suicide Attempt |
0.9% |
Major Depression |
0.8% |
Foetal Exposure During Pregnancy |
0.8% |
Tachyarrhythmia |
0.8% |
Completed Suicide |
0.7% |
Drug Exposure During Pregnancy |
0.7% |
Intentional Overdose |
0.7% |
|
Completed Suicide |
24.2% |
Respiratory Arrest |
14.5% |
Toxicity To Various Agents |
5.3% |
Cardio-respiratory Arrest |
4.6% |
Suicide Attempt |
4.5% |
Death |
4.3% |
Drug Toxicity |
4.1% |
Weight Increased |
4.0% |
Tremor |
3.6% |
Vomiting |
3.5% |
Somnolence |
3.2% |
Withdrawal Syndrome |
3.2% |
Cardiac Arrest |
3.0% |
Drug Ineffective |
3.0% |
Poisoning |
3.0% |
Overdose |
2.8% |
Serotonin Syndrome |
2.5% |
Suicidal Ideation |
2.4% |
Drug Abuse |
2.1% |
Intentional Drug Misuse |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
19.8% |
Drug Use For Unknown Indication |
15.1% |
Depression |
14.2% |
Pain |
6.5% |
Insomnia |
5.6% |
Anxiety |
5.1% |
Bipolar Disorder |
5.0% |
Sleep Disorder |
4.2% |
Hypertension |
4.1% |
Rheumatoid Arthritis |
3.3% |
Multiple Sclerosis |
2.2% |
Diabetes Mellitus |
1.9% |
Gastrooesophageal Reflux Disease |
1.9% |
Schizophrenia |
1.9% |
Hepatitis C |
1.8% |
Osteoporosis |
1.6% |
Blood Cholesterol Increased |
1.5% |
Asthma |
1.5% |
Crohn's Disease |
1.4% |
Migraine |
1.3% |
|
Weight Increased |
14.0% |
Type 2 Diabetes Mellitus |
13.6% |
Vomiting |
10.4% |
Weight Decreased |
8.1% |
Tremor |
5.1% |
Suicidal Ideation |
4.5% |
Pain |
4.1% |
Drug Ineffective |
3.8% |
Vision Blurred |
3.8% |
Nausea |
3.5% |
Urinary Tract Infection |
3.5% |
Suicide Attempt |
3.1% |
Rash |
3.1% |
Pancreatitis |
3.0% |
Pneumonia |
2.9% |
Somnolence |
2.8% |
White Blood Cell Count Decreased |
2.8% |
Death |
2.7% |
Insomnia |
2.6% |
Wrong Technique In Drug Usage Process |
2.6% |
|
Interacting |
Drug Use For Unknown Indication |
24.6% |
Depression |
17.0% |
Parkinson's Disease |
7.8% |
Diabetes Mellitus |
6.9% |
Bipolar Disorder |
5.0% |
Pain |
5.0% |
Dementia |
4.9% |
Product Used For Unknown Indication |
4.9% |
Atrial Fibrillation |
3.4% |
Tachyarrhythmia |
3.4% |
Dementia With Lewy Bodies |
2.9% |
Insomnia |
2.6% |
Anxiety |
1.9% |
Sleep Disorder |
1.9% |
Dyslipidaemia |
1.7% |
High Density Lipoprotein Decreased |
1.6% |
Blood Cholesterol Increased |
1.4% |
Crying |
1.4% |
Chronic Hepatitis |
0.9% |
Convulsion |
0.9% |
|
Drug Interaction |
19.8% |
Myocardial Infarction |
13.2% |
Vomiting |
7.7% |
Dysstasia |
6.6% |
Erythema |
6.6% |
Blood Pressure Increased |
5.5% |
Serotonin Syndrome |
4.4% |
Tongue Disorder |
4.4% |
Abnormal Behaviour |
3.3% |
Hepatic Encephalopathy |
3.3% |
Parkinsonism |
3.3% |
Prescribed Overdose |
3.3% |
Urinary Retention |
3.3% |
Coma |
2.2% |
Depressed Level Of Consciousness |
2.2% |
Depression |
2.2% |
Drug Level Decreased |
2.2% |
Electrocardiogram St Segment Elevation |
2.2% |
Electrocardiogram T Wave Peaked |
2.2% |
Head Injury |
2.2% |
|